Veltro Argento — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Adagio TherapeuticsNASDAQ: IVVDJul 2020SEC filingmedium confidence
BiotechWaltham, US
Tillman U. Gerngross(Executive Officer, Director)Lynn Connolly(Executive Officer)Eric Kimble(Executive Officer)Halley Gilbert(Executive Officer)Rebecca Dabora(Executive Officer)Ellie Hershberger(Executive Officer)
Board seatMarc Elia· per SEC Form D · $23.7M raise · filed Nov 2022
Co-investorsMithril Capital ManagementPolaris Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.